OrthoNeuro Surgeon Performs the First Robotics-Assisted Bi-Cruciate

Retaining Total Knee Replacement with the NAVIO Surgical System in Ohio

Columbus, OH, December 19, 2017 --(PR.com)-- Dr. Mark Gittins, OrthoNeuro Orthopedic Surgeon
completed the first robotics-assisted bi-cruciate retaining total knee replacement procedure in Ohio. This
surgical milestone occurred on November 28, 2017 at the New Albany Surgery Center and represents one
of the first CT-free robotics-assisted bi-cruciate total knee arthroplasty procedures using the NAVIO
Surgical System in the world.

The NAVIO robotics-assisted surgical system aids in implanting the JOURNEY II XR (bi-cruciate
retaining total knee system) which is one of the only total knee designs allowing retention of the ACL,
and is designed to improve patient satisfaction. (1)

Having used robotics-assisted technology for partial knee arthroplasty before, it was easy to understand
how the same benefits could translate to total knee arthroplasty, said Dr. Gittins. I'm excited for the
future of this technology and what it means for my patients.

According to Dr. Mark Gittins, unlike other total knee implants that remove the anterior and posterior
cruciate ligaments (ACL/PCL), the JOURNEY II XR knee implant uses a U-shaped tibial base plate that
allows these ligaments to remain in place after surgery. The JOURNEY II XR implant also features an
anatomic design that helps to reproduce the original internal shapes and forces of a natural knee as it goes
through its full range of motion.

The NAVIO is a next generation handheld robotics platform designed to aid surgeons with implant
alignment, ligament balancing and bone preparation - key factors that can drive implant survivorship.
(2,3) The small footprint of NAVIO allows for set up and portability. Furthermore, the NAVIO
robotics-assisted system does not require a preoperative image, such as a CT scan. This allows patients to
receive the benefits of robotics-assistance without the extra steps, costs, and radiation associated with
additional preoperative imaging. (4)

References
(1) Moro-Oka, Taka-Aki, Marc Muenchinger, Jean Pierre Canciani, and Scott A. Banks.Comparing in
Vivo Kinematics of Anterior Cruciate-retaining and Posterior Cruciate-retaining Total Knee
Arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy 15.1 (200&): 93:99. Web.
(2) Sharkey, P., et al. Why Are Total Knee Arthroplasties Failing Today? Clinical Orthopaedics and
Related Research. 2002 Nov;404:7-13.
(3) Siddique, N., Ahmad, Z. Revision of Unicondylar to Total Knee Arthroplasty: A Systematic
Review The Open Orthopaedics Journal 2012;6; (Suppl 2: M2) 268-275
(4) Sg2 Healthcare Intelligence. Technology Guide: Orthopedic Surgical Robotics. 2014.25.
Readmissions Reduction Program (HRRP). CMS.gov. Page last Modified: 04/18/2016 5:08 PM.

OrthoNeuro
OrthoNeuro is a multidisciplinary center of board-certified physicians specializing in orthopedic surgery,

Page 1/4
PR.com Press Release Distribution Terms of Use
neurology, neurosurgery, and physical medicine and rehabilitation. With offices in Westerville, New
Albany, Grandview, Pickerington, and Dublin, OrthoNeuro is committed to providing patients throughout
Greater Central Ohio with convenient access to an exceptional patient care. For more information about
OrthoNeuro visit www.orthoneuro.com or call 614-890-6555.

New Albany Surgery Center

New Albany Surgery Center is a single specialty ambulatory surgery center that has been open for 5 years
specializing in orthopedic procedures. For more information about New Albany Surgery Center visit
www.newalbanysurgerycenter.com or call 614-775-1616.

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals
improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound
Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000
employees and a presence in more than 100 countries. Annual sales in 2016 were almost $4.7 billion.
Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE: SNN).

For more information about Smith & Nephew, please visit their website www.smith-nephew.com, follow
@SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.

Individual results may vary.

Not all patients are candidates for the JOURNEY II XR Knee Implant or the NAVIO Surgical System.
Discuss your condition and implant options with your surgeon. Individual results of joint replacement
vary. Implants are intended to relieve knee pain and improve function, but may not produce the same feel
or function as your original knee. There are potential risks with knee replacement surgery such as
loosening, wear and infection that may result in the need for additional surgery. Patients should not
perform high impact activities such as running and jumping unless their surgeon tells them that the bone
has healed and these activities are acceptable. Early device failure, breakage or loosening may occur if a
surgeon's limitations on activity level are not followed. Children, pregnant women, patients who have
mental or neuromuscular disorders that do not allow control of the knee joint, and morbidly obese
patients should not undergo a NAVIO procedure. This information is for educational purposes only and is
not intended as medical advice. Consult your physician for details to determine if one of these
technologies is right for you.

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For
example, statements regarding expected revenue growth and trading margins, market trends and our
product pipeline are forward-looking statements. Phrases such as "aim," "plan," "intend," "anticipate,"
"well-placed," "believe," "estimate," "expect," "target," "consider" and similar expressions are generally
intended to identify forward-looking statements. Forward-looking statements involve known and
unknown risks, uncertainties and other important factors that could cause actual results to differ

Page 2/4
PR.com Press Release Distribution Terms of Use
materially from what is expressed or implied by the statements. For Smith & Nephew, these factors
include: economic and financial conditions in the markets we serve, especially those affecting health care
providers, payers and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement decisions or other government
actions; product defects or recalls or other problems with quality management systems or failure to
comply with related regulations; litigation relating to patent or other claims; legal compliance risks and
related investigative, remedial or enforcement actions; disruption to our supply chain or operations or
those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and
dispositions, our success in performing due diligence, valuing and integrating acquired businesses;
disruption that may result from transactions or other changes we make in our business plans or
organization to adapt to market developments; and numerous other matters that affect us or our markets,
including those of a political, economic, business, competitive or reputational nature. Please refer to the
documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the
U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual
report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based
on information available to Smith & Nephew as of the date of the statement. All written or oral
forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith &
Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect
any change in circumstances or in Smith & Nephew's expectations.

Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.

Page 3/4
PR.com Press Release Distribution Terms of Use
Contact Information:
OrthoNeuro
Heather Benjamin
614-839-2142
Contact via Email
www.orthoneuro.com
Director of Marketing and Communications

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/739455

News Image:

Page 4/4
PR.com Press Release Distribution Terms of Use